Logo image
Sign in
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients with COVID-19
Journal article   Open access  Peer reviewed

Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients with COVID-19

N. Gupta, L. Settle, B. R. Brown, D. L. Armaignac, M. Baram, N. E. Perkins, M. Kaufman, R. R. Melamed, A. B. Christie, V. C. Danesh, …
Critical Care Medicine, Vol.50(10)
2022

Abstract

antihypertensive agents COVID-19 mortality outcome renin-angiotensin-aldosterone system inhibitors beta adrenergic receptor blocking agent calcium channel blocking agent diuretic agent angiotensin receptor antagonist antihypertensive agent dipeptidyl carboxypeptidase inhibitor adult APACHE Article artificial ventilation comparative study continuous renal replacement therapy controlled study coronavirus disease 2019 extracorporeal oxygenation female hospital admission hospital discharge hospital patient hospitalization human hypertension in-hospital mortality information processing informed consent length of stay major clinical study male medical record multicenter study observational study outcome assessment people by smoking status renin angiotensin aldosterone system retrospective study survival time clinical trial middle aged Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Humans Renin-Angiotensin System Retrospective Studies
url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138445319&doi=10.1097%2fCCM.0000000000005627&partnerID=40&md5=77747ad4d618e58f5c8ec1329a8265d5View
url
https://doi.org/10.1097/CCM.0000000000005627View
Published (Version of record) Open

Details